Juanita Lopez
National Health Service, United Kingdom · National Health Service, UK · Royal Marsden Hospital NHS Foundation Trust
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Juanita Lopez as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:10 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT07391215 · 5G-PEARL: Paxalisib in Malignant Brain TumoursInstitute of Cancer Research, United Kingdom · recruiting · Malignant Primary Gliomas, Glioblastoma Multiforme (GBM) · study director
- Ph1NCT06632236 · 5G-EMERALD: Amivantamab in Malignant Brain TumoursInstitute of Cancer Research, United Kingdom · active not recruiting · Malignant Primary Gliomas, Glioblastoma Multiform (Grade IV Astrocytoma), Diffuse Hemispheric Glioma, H3 G34-Mutant · study director
- Ph1/Ph2NCT06630260 · 5G-RUBY: Avutometinib and Defactinib in Malignant Brain TumoursInstitute of Cancer Research, United Kingdom · recruiting · Glioblastoma Multiforme (GBM), Glioblastoma Multiform (Grade IV Astrocytoma), Diffuse Hemispheric Glioma, H3 G34-Mutant · study director
- Ph1NCT05082259 · ASTEROID: A Trial of ASTX660 in Combination With PembrolizumabInstitute of Cancer Research, United Kingdom · active not recruiting · Advanced Cancer, Cervical Cancer, Triple Negative Breast Cancer · study director
- N/ANCT04407676 · Improving Informed Consent for Early Phase Anti-Cancer TrialsRoyal Marsden NHS Foundation Trust · unknown · Solid Neoplasms · principal investigator
- Ph1/Ph2NCT03673787 · A Trial of Ipatasertib in Combination With AtezolizumabInstitute of Cancer Research, United Kingdom · active not recruiting · Solid Tumor, Glioblastoma Multiforme, Prostate Cancer Metastatic · principal investigator
- Ph1/Ph2NCT01792310 · A Phase 1/2A Study of LAM561 in Adult Patients With Advanced Solid TumoursLaminar Pharmaceuticals · completed · Glioma, Other Solid Tumours · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:10 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 09:10 UTC. The ranking covers the 200 most relevant of 265 PubMed records, and a shared surname and initials can bring in a namesake. All 265 on PubMed
- 2,186 citationsRCR 94.0
- 961 citationsRCR 29.7
- The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis.Circulation · 2003826 citationsRCR 17.9
- 780 citationsRCR 26.8
- Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease.N Engl J Med · 2022525 citationsRCR 39.7
- Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma.N Engl J Med · 2013452 citationsRCR 11.9
- Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results From the KEYNOTE-028 Study.J Clin Oncol · 2017413 citationsRCR 12.9
- Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease.Circulation · 2022341 citationsRCR 26.0
- Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.Arch Neurol · 2005332 citationsRCR 8.3
- GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus.N Engl J Med · 2012258 citationsRCR 6.7